Arvind Remedies Ltd. said its board had declared a dividend of 10 percent Re.1.00 per equity share of Rs.10 each,which includes two percent special dividend due to Silver Jubilee year.
The board also approved the De-merger of Irungattukottai Unit of the company into their wholly-owned subsidiary (WOS), Arvind Wellness Ltd. and fixed the appointed date as April 08, 2013. It was noted that the resultant company (WOS) will be issuing preference share to the shareholders of Arvind Remedies, as a part of the de-merger scheme.
For the fiscal year, the company reported a stand-alone net profit of Rs.40.62 crore, compared with Rs.19.41 crore in 2012, reflecting a 109 percent growth. Total net income, including other operating income, was Rs.664.26 crore, higher by 52 percent than the Rs.436.63 crore a year-ago.
On a consolidated basis, its fiscal year net profit, after minority interest, surged by 108 percent to Rs.43.39 crore from the Rs.20.87 crore last year. Total net income, including other operating income, amounted to Rs.706.12 crore, up by 51 percent from the Rs.467.73 crore in 2012.
At the BSE, Arvind Remedies shares are currently trading at Rs.34, up 3.34 percent from the previous close.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.